InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-23.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Connelly Stephen, Directeur Scientifique. Officer active across 1 company, notably Equillium, Inc.. In total, 6 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €623k. History available since 4 June 2021. The latest transaction was disclosed on 4 June 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
200,000 shares@ US$3.16380.28% mcap77.9% of flowCommon StockSEC:0001746808-26-000004:0
30,975 shares@ US$2.94010.041% mcap11.2% of flowCommon StockSEC:0001746808-26-000004:1
5,625 shares@ US$4.7530.3% of flowCommon StockSEC:0001209191-21-060004
5,625 shares@ US$4.750.017% mcap30.3% of flowCommon StockSEC:0001209191-21-060004:0
6,509 shares@ US$2.800.011% mcap19.7% of flowCommon StockSEC:0001209191-21-039081:0
6,509 shares@ US$2.8019.7% of flowCommon StockSEC:0001209191-21-039081
6 of 6 declarations
About Connelly Stephen
Stephen Connelly is the Chief Scientific Officer at Equillium, Inc. He plays a key role in the scientific direction of the company, overseeing research and the development of new products. His expertise in the scientific field is essential in guiding Equillium's initiatives and ensuring innovation.
